← Browse by Condition
Medical Condition

relapsed or refractory b cell leukemia and lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06834529 Phase 1, Phase 2
Recruiting

CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma

Enrollment
20 pts
Location
China
Sponsor
Affiliated Hospital to Academy...
View Trial →